Table 1.
Vaccination coverage of Oxford-AstraZeneca (ChAdOx1-S) and Pfizer-BioNTech (BNT162b2) vaccines according to covid-19 test result at end of study period (21 February), by age group. Values are numbers (percentages) unless stated otherwise
| ChAdOx1-S | BNT162b2 | Any vaccine | Unvaccinated | Total No | |
|---|---|---|---|---|---|
| Positive test result | |||||
| Age group (years): | |||||
| 70-74 | 10 073 (50) | 4932 (24) | 15 005 (74) | 5214 (25.8) | 20 219 |
| 75-79 | 5227 (47) | 3196 (28) | 8423 (75) | 2816 (25.1) | 11 239 |
| 80-84 | 2320 (36) | 2706 (42) | 5026 (77) | 1487 (22.8) | 6513 |
| 85-89 | 1355 (35) | 1356 (35) | 2711 (70) | 1180 (30.3) | 3891 |
| ≥90 | 985 (36) | 682 (25) | 1667 (61) | 1061 (38.9) | 2728 |
| Total | 19 960 (45) | 12 872 (29) | 32 832 (74) | 11 758 (26.4) | 44 590 |
| Negative test result | |||||
| Age group (years): | |||||
| 70-74 | 33 756 (59) | 20 251 (35) | 54 007 (95) | 3137 | 57 144 |
| 75-79 | 14 605 (50) | 13 375 (45) | 27 980 (95) | 1439 | 29 419 |
| 80-84 | 3955 (28) | 9366 (67) | 13 321 (95) | 721 | 14 042 |
| 85-89 | 2243 (30) | 4559 (62) | 6802 (92) | 555 | 7357 |
| ≥90 | 1866 (43) | 2061 (47) | 3927 (90) | 451 | 4378 |
| Total | 56 425 (50) | 49 612 (44) | 106 037 (94) | 6303 | 112 340 |